Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
FDA Approves First Biosimilar Etanercept
The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept.
Second Biosimilar Gets FDA Nod
The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.
8 Signs of Psoriatic Arthritis
Unequal Treatment for Psoriasis?
The type of medical care patients get depends on several factors. Some patients with psoriasis, or the arthritis that can accompany psoriasis, don't believe they get enough quality care.
Physically Active with Psoriatic Arthritis
Psoriasis is known for uncomfortable itchy and dry patches that develop on the skin, and some may think these are the only things to know about the condition. However, certain patients will develop the more internal symptoms of psoriatic arthritis as time goes on.
No Safety Surprises from Humira
Humira (adalimumab) is a medication used to treat a variety of diseases. As the medication is being prescribed to more and more patients, researchers wanted to see if there were any side effects they didn't know about before.
Arava Worked in the "Real World"
Arava ( leflunomide ) is one of the many drugs used to fight inflammation - a central feature of psoriatic arthritis. The drug may appear to work well in a research environment, but how does it fare in the "real world"?